Stay updated on Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial

Sign up to get notified when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows a minor version update from v3.4.1 to v3.4.2; no study content or functionality changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:55.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision banner updated from v3.4.0 to v3.4.1; no impact on study information or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T17:24:14.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.4, replacing the previous v3.3.3. No study details, eligibility criteria, or other core information were altered.
    Difference
    0.1%
    Check dated 2026-01-15T03:52:12.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page adds a footer revision note 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the previous revision note 'Revision: v3.3.2' were removed.
    Difference
    0.1%
    Check dated 2025-12-24T16:33:12.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    - Results Submitted added to the study record, and the revision updated to v3.3.2, replacing No Results Posted and v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:42:07.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The notification about government funding and operating status was removed from the page; this does not affect the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:30.000Z thumbnail image

Stay in the know with updates to Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.